Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
James A WatsonWalter R J TaylorGermana BanconeCindy S ChuPodjanee JittamalaNicholas J WhitePublished in: PLoS neglected tropical diseases (2018)
If tafenoquine is deployed for radical cure, primaquine will still be needed to obtain high population coverage. Better radical cure antimalarial regimens are needed.